Personnel Information

写真a

ONO Hiroaki


Job title

Assistant Professor

Research Areas, Keywords

Surgical Oncology,HBP surgery,Gastroenterological surgery, Chemotherapy,Neuroendocrine tumor, Multidisciplinary treatment

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 2002.03, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Graduate School, Division of Medicine, Doctor's Course, 2011.03, Completed

Campus Career 【 display / non-display

  • 2007.10
    -
    2017.03
    Tokyo Medical and Dental University, Research and Industry-University Alliance Organization, Bioresource Research Center, Project Assistant Professor
  • 2017.04
    -
    2019.10
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Hepato-Biliary-Pancreatic Surgery, Assistant Professor
  • 2019.11
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Hepatobiliary and Pancreatic Surgery, Assistant Professor

External Career 【 display / non-display

  • 2012.05
    -
    2016.02
    Michigan State University, USA, Department of Surgery, Postdoctoral Fellow

Research Areas 【 display / non-display

  • Molecular biology

  • Digestive surgery

Qualification Acquired 【 display / non-display

  • Doctor

 

Research Theme 【 display / non-display

  • Surgical Oncology

Published Papers & Misc 【 display / non-display

  • Yoshiki Murase, Hiroaki Ono, Kosuke Ogawa, Risa Yoshioka, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers Cancer Science. 2021.09; Early View ( DOI )

  • Satoshi Matsui, Hiroaki Ono, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Pancreatic metastasis from renal cell carcinoma presenting as gastrointestinal hemorrhage: a case report Jornal of Surgical Case Reports. 2021.08; 2021 (8): rjab368.

  • Tomotaka Kato,Hiroaki Ono, Mikiya Fujii, Keiichi Akahoshi, Toshiro Ogura, Kosuke Ogawa, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PLoS One. 2021.06; 16 (6): e0252917.

  • Hiroyuki Ishida, Yoshiya Ishikawa, Keiichi Akahoshi, Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe.. Laparoscopic distal pancreatectomy in a patient with aberrant splenic artery originating from the superior mesenteric artery: A case report 2021.05; 100 (18): e25704.

  • Hiroaki Ono, Tomotaka Kato, Yoshiki Murase, Yutaro Nakamura, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Toshiro Ogura, Kosuke Ogawa, Daisuke Ban, Atsushi Kudo, Yoshimitsu Akiyama, Shinji Tanaka, Hiromichi Ito, Minoru Tanabe . C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer Scientific Reports. 2021.05; 11 (1): 10078.

display all >>

Conference Activities & Talks 【 display / non-display

  • Kohei Yagi, Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Yoshiki Murase, Aya Maekawa, Takeshi Ishii, Toshitaka Sugawara, Shuichi Watanabe, Yoshiya Ishikawa, Keiichi Akashoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, SHinji Tanaka, Minoru Tanabe. A review of resected cases of primary duodenal cancer in our hospital. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  • Hironari Yamashita, Keiichi Akahoshi, Koichirou Morimoto, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Takeshi Ishii, Toshitaka Sugawara, Yoshiya Ishikawa, Hiroki Ueda, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Effect of neoadjuvant chemotherapy on short-term outcome in patients undergoing pancreaticoduodenectomy for borderline resectable pancreatic cancer and resectable pancreatic cancer with elevated serum tumor markers. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  • Kosuke Ogawa, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Hiroaki Ono, Atsushi Kudo, Minoru Tanabe. Analysis of completion rate of Gemcitabine/Nabpaclitaxel combination therapy for pancreatic cancer before and after pancreatectomy. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  • Hiroaki Ono, Atsushi Kudo, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Shinji Tanaka, Minoru Tanabe. Combination of Weekly Streptozocin and Oral S-1 Treatment is effective treatment for unresectable or metastatic pancreatic NET-G1 and NET-G2 patients. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

  • Hiroki Ueda, Koichiro Morimoto, Hironari Yamashita, Hiroyuki Ishida, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Perioperative outcomes in elderly patients over 75-years-old undergoing distal pancreatectomy. The 33rd Meeting of Japanese Society of Hepato-Billiary-Pancreatic Surgery 2021.06.02 Osaka

display all >>

Awards & Honors 【 display / non-display

  • The Best Presenter Award in International Session,2019.12

  • Distinguished Poster,SSAT, USA,2014.05

  • Distinguished Poster,SSAT, USA,2013.05